On January 22, 2010, the U.S. Food and Drug Administration (FDA) approved AMPYRA® (dalfampridine) Extended Release Tablets,...
Zanaflex Capsules® (tizanidine hydrochloride) is a short-acting drug for the management of spasticity. Because of the short...